ELEV — Elevation Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- $144.25m
- $71.00m
- 24
- 24
- 81
- 39
Annual cashflow statement for Elevation Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.88 | -17.3 | -32 | -95.1 | -45.7 |
| Depreciation | |||||
| Non-Cash Items | 0.009 | 0.052 | 1.57 | 3.28 | 3.17 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.423 | 4.9 | 0.283 | 6.29 | -13.7 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -5.45 | -12.3 | -30.2 | -85.5 | -56.2 |
| Capital Expenditures | 0 | -0.071 | 0 | -0.086 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -44.3 | 11.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -0.071 | 0 | -44.4 | 11.5 |
| Financing Cash Flow Items | -0.077 | -0.174 | -0.011 | -0.47 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.19 | 90 | 97.1 | 29.5 | 48 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.74 | 77.7 | 66.9 | -100 | 3.34 |